NASHVILLE, Tenn. / Sep 30, 2024 / Business Wire / HealthStream (Nasdaq: HSTM), a leading healthcare technology platform for workforce solutions, unveiled an array of CredentialStream® innovations at the NAMSS 2024 Conference. CredentialStream, an industry-leading Credentialing solution for healthcare organizations, continues to expand its market-leading capabilities.
“We are proud to announce these new credentialing, privileging, and enrollment innovations,” said Michael J. Sousa, Executive Vice President of Enterprise Applications at HealthStream. “Collectively, these new capabilities will enable our clients to accelerate time to revenue, rapidly validate credentials, and boost the provider experience.”
Key announcements include:
“We’re excited to showcase these industry-leading capabilities at NAMSS 2024,” said Sousa. “We believe that accelerating the onboarding process for providers—including a myriad of tasks across medical staff credentialing, privileging, enrollment, health plan credentialing, compliance training, EMR provisioning, CME management, and provider evaluation—can best be achieved with a single application that automates all of these tasks and delivers a one-stop for providers.”
HealthStream is presenting these groundbreaking innovations alongside its other premier products at NAMSS24 in Denver. Attendees are invited to explore the HealthStream booth at #603 and participate in the enlightening Solution Showcase presentation, “Credentialing and Privileging are Critical: Win with CredentialStream,” during the event on Monday, Sept 30, 2024, 11:45 a.m.-12:05 p.m. MDT in the Solution Showcase area in the exhibit hall.
About HealthStream
HealthStream (Nasdaq: HSTM) is the healthcare industry’s largest ecosystem of platform-delivered workforce solutions that empowers healthcare professionals to do what they do best: deliver excellence in patient care. For more information, visit http://www.healthstream.com or call 800-521-0574.
This press release contains forward-looking statements that involve risks and uncertainties regarding HealthStream. This information has been included in reliance on the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such results or events predicted in these statements may differ materially from actual future events or results. These forward-looking statements are based on a variety of assumptions that may not be realized, and which are subject to significant risks and uncertainties, including that the anticipated financial and strategic benefits of the acquisition may not be realized, as well as risks and uncertainties referenced from time to time in the Company’s filings with the Securities and Exchange Commission.
Last Trade: | US$30.07 |
Daily Change: | 1.62 5.69 |
Daily Volume: | 179,996 |
Market Cap: | US$914.430M |
October 21, 2024 July 22, 2024 April 22, 2024 February 19, 2024 December 05, 2023 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB